Scientists at the Icahn School of Medicine at Mount Sinai have developed a lipid nanoparticle system capable of delivering ...

Reducing intravenous (IV) isatuximab delivery from 75 minutes to 30 minutes could provide a wealth of benefits to patients ...

The results increase “my confidence that this approach has merit,” Lauren Sansing says. More trials are on the way.

Finnish biopharmaceutical company Aplagon has secured a financing of €7m ($7.24m) to advance its heparin proteoglycan mimetic, APAC, to primarily support the initiation of a Phase IIa trial for ...

Aplagon announces EUR 7 million financing to advance its APAC therapeutic for thrombo-inflammatory diseases into phase 2A trials: Helsinki Tuesday, February 4, 2025, 16:00 Hrs [IS ...

During this period, each center prospectively applied one of three periprocedural protocols: (a) two centers administered aspirin (250 mg IV); (b) one center administered aspirin and heparin (bolus+24 ...

Intraoperative heparin was administered in six patients (42.9%), and five of these had a postoperative heparin infusion. A single intraoperative IV dose of the GPIIb/IIIa inhibitor, abciximab, was ...

For decades, unfractionated heparin (hereafter, heparin) has been the primary anticoagulant used for extracorporeal membrane oxygenation (ECMO) support. More recently, however, bivalirudin, a direct ...

uhn.on.ca Objective Assess the impact of infusion pump technologies (traditional pump vs smart pump vs smart pump with barcode) on nurses' ability to safely administer intravenous medications. Design ...

Investing in DRIP stocks can be an efficient way for Canadian investors to harness compound growth. But they’re not for everyone. Below we’ll break down DRIP stocks and help you decide if they ...

Other forms of ketamine – none of which have FDA approval for mental health conditions – include IV infusion or a shot in the arm, or oral compounded formulations. Most research looks at ...